Sirolimus Side Effects
Applies to sirolimus: oral solution, oral tablet.
Important warnings
This medicine can cause some serious health issues
Oral route (solution; tablet)
Increased susceptibility to infection and the possible development of lymphoma and other malignancies may result from immunosuppressionIncreased susceptibility to infection and the possible development of lymphoma may result from immunosuppression.
Only physicians experienced in immunosuppressive therapy and management of renal transplant patients should use sirolimus for prophylaxis of organ rejection in patients receiving renal transplants.
Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources.
The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.The safety and efficacy of sirolimus as immunosuppressive therapy have not been established in liver or lung transplant patients, and therefore, such use is not recommended.Liver Transplantation - Excess Mortality, Graft Loss, and Hepatic Artery Thrombosis (HAT)The use of sirolimus in combination with tacrolimus was associated with excess mortality and graft loss in a study in de novo liver transplant patients.
Many of these patients had evidence of infection at or near the time of death.
In this and another study in de novo liver transplant patients, the use of sirolimus in combination with cyclosporine or tacrolimus was associated with an increase in HAT; most cases of HAT occurred within 30 days post-transplantation and most led to graft loss or death.Lung Transplantation - Bronchial Anastomotic Dehiscence. Cases of bronchial anastomotic dehiscence, most fatal, have been reported in de novo lung transplant patients when sirolimus has been used as part of an immunosuppressive regimen.
Precautions
It is very important that your doctor check your or your child's progress at regular visits to make sure that this medicine is working properly. Blood and urine tests may be needed to check for unwanted effects.
Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant, and keep using it for at least 12 weeks after you stop taking sirolimus. If you think you have become pregnant while using the medicine, tell your doctor right away.
If you are planning to have children, talk with your doctor before using this medicine. Some men and women using this medicine have become infertile (unable to have children).
Using this medicine may increase your risk of getting skin cancer or cancer of the lymph system (lymphoma). Talk to your doctor if you have concerns about this risk.
This medicine may increase your risk of developing infections. Avoid being near people who are sick while you are using this medicine. Wash your hands often. Tell your doctor if you have any kind of infection before you start using this medicine. Tell your doctor if you have ever had an infection that would not go away or an infection that kept coming back.
Sirolimus may cause serious types of allergic reactions, including anaphylaxis,, which can be life-threatening and require immediate medical attention. Call your doctor right away if you or your child has a rash, itching, red, swollen skin, trouble breathing, trouble swallowing, or chest tightness while you are using this medicine.
Sirolimus may cause a serious type of allergic reaction called angioedema. This may occur more often when it is used with certain heart and blood pressure medicines called ACE inhibitors (eg, captopril [Capoten®], enalapril [Vasotec®], fosinopril [Monopril®], quinapril [Accupril®], ramipril [Altace®]). Check with your doctor right away if you have a rash, itching, a large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals, trouble breathing, or chest tightness while you are using this medicine.
This medicine may also increase your risk of bleeding and cause delay in wound healing. Stay away from rough sports or other situations where you could be bruised, cut, or injured. Brush and floss your teeth gently. Be careful when using sharp objects, including razors and fingernail clippers. Check with your doctor immediately if you or your child notice any unusual bleeding or bruising, black, tarry stools, blood in the urine or stools, or pinpoint red spots on your skin.
This medicine may increase your cholesterol and fats in the blood. If this condition occurs, your doctor may give you or your child some medicines that can lower the amount of cholesterol and fats in the blood.
This medicine may increase your risk of developing a rare and serious virus infection called BK virus-associated nephropathy (BKVAN). The BK virus may affect how your kidneys work and cause a transplanted kidney to fail. Check with your doctor right away if you or your child has bloody urine, a decreased frequency or amount of urine, increased thirst, loss of appetite, lower back or side pain, nausea, swelling of the face, fingers, or lower legs, trouble breathing, unusual tiredness or weakness, vomiting, or weight gain.
This medicine may cause a serious lung problem called interstitial lung disease or non-infectious pneumonitis. Check with your doctor right away if you have chest pain, chills, cough, fever, or trouble breathing.
This medicine may increase your risk of developing a serious and rare brain infection called progressive multifocal leukoencephalopathy (PML). Check with your doctor right away if you or your child has vision changes, loss of coordination, clumsiness, confusion, memory loss, difficulty speaking or understanding what others say, and weakness in the legs.
This medicine may make your skin more sensitive to sunlight and can increase your risk of having skin cancer. Use a sunscreen when you are outdoors and avoid sunlamps and tanning beds.
While you are being treated with sirolimus, and after you stop treatment with it, it is important to see your doctor about the immunizations (vaccinations) you should receive. Do not get any immunizations (vaccines) without your doctor's approval. Sirolimus may lower your body's resistance and there is a chance you might get the infection the vaccine is meant to prevent. In addition, you should not be around other persons living in your household who receive live virus vaccines because there is a chance they could pass the virus on to you. Some examples of live vaccines include measles, mumps, influenza (nasal flu vaccine), poliovirus (oral form), rotavirus, and rubella. Do not get close to them and do not stay in the same room with them for very long. If you have questions about this, talk to your doctor.
Check with your doctor right away if you notice a new mole, a change in size, shape or color of an existing mole, or a mole that leaks fluid or bleeds.
While you are taking sirolimus, it is important to maintain good dental hygiene and see a dentist regularly for teeth cleaning.
Raw oysters or other shellfish may contain bacteria that can cause serious illness and possibly death. This is more likely to be a problem if these foods are eaten by patients with certain medical conditions. Even eating oysters from “clean” water or good restaurants does not guarantee that the oysters do not contain the bacteria. Eating raw shellfish is not a problem for most healthy people, however, patients with the following conditions may be at greater risk: cancer, immune disorders, organ transplantation, long-term corticosteroid use (as for asthma, arthritis, or organ transplantation), liver disease (including viral hepatitis), excess alcohol intake (2 to 3 drinks or more per day), diabetes, stomach problems (including stomach surgery and low stomach acid), and hemochromatosis (an iron disorder). Do not eat raw oysters or other shellfish while you are taking sirolimus. Be sure oysters and shellfish are fully cooked.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal (eg, St. John's wort) or vitamin supplements.
Serious side effects of sirolimus
Along with its needed effects, sirolimus may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking sirolimus:
More common side effects
- accumulation of pus
- anxiousness, unexplained
- backache
- black or red, tarry stools
- bleeding from the gums or nose
- blurred vision
- body aches or pain
- bone pain
- bruising
- burning or stinging of the skin
- burning while urinating
- burning, dry, or itching eyes
- burning, tingling, numbness, or pain in the hands, arms, feet, or legs
- change in mental status
- changes in skin color
- chest pain
- chills
- confusion
- cough
- dark or bloody urine
- deafness
- decreased urine output
- decreased vision
- difficulty with breathing or swallowing
- dilated neck veins
- discharge from the eyes
- dizziness
- drowsiness
- dry mouth
- earache
- excessive tearing
- eye pain
- facial hair growth in females
- faintness or lightheadedness when getting up from lying or sitting position
- fast, slow, or irregular heartbeat
- fever
- flushing or redness of the skin, especially on the face and neck
- general feeling of discomfort or illness
- increased hunger
- increased menstrual flow or vaginal bleeding
- itching, pain, redness, swelling, tenderness, or warmth on the skin
- lack or loss of appetite
- large, flat, blue, or purplish patches in the skin
- loss of sexual ability, desire, drive, or performance
- loss of voice
- muscle pain
- nasal congestion
- nausea or vomiting
- numbness or tingling around the lips, hands, or feet
- pain in the chest, groin, or legs, especially the calves
- painful cold sores or blisters on the lips, nose, eyes, or genitals
- pale skin
- prolonged bleeding from cuts
- rapid heartbeat
- rash
- red or dark brown urine
- redness or swelling in the ear
- redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
- ringing in the ears
- runny nose
- seizures
- sensation of pins and needles
- severe constipation
- severe vomiting
- severe, sudden headache
- slurred speech
- sore throat
- sores or white spots on the lips or in the mouth
- stomach cramps, pain, or upset
- sudden decrease in the amount of urine
- sudden loss of coordination
- sudden, severe weakness or numbness in the arm or leg
- sweating
- swollen, painful, or tender lymph glands in the neck, armpit, or groin
- tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over affected area
- tremor
- ulcers on the lips or in the mouth
- unusual tiredness or weakness
- vision changes
- weakness or heaviness of the legs
- white patches in the mouth or on the tongue
- yellow skin and eyes
Less common side effects
- bloating
- change in size, shape, or color of existing mole
- hoarseness
- mole that leaks fluid or bleeds
- new mole
- pains in the stomach, side or abdomen, possibly radiating to the back
- skin ulcer or sores
Incidence not known
- abnormal wound healing
- headache
- hives or itching
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- nails loose or detached
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- swelling of the arms or legs
- yellow nails lacking a cuticle
Other side effects of sirolimus
Some side effects of sirolimus may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- abnormal vision
- acne
- belching
- blistering, crusting, irritation, itching, or reddening of the skin
- burning feeling in the chest or stomach
- burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feeling
- constipation
- continuing ringing or buzzing or other unexplained noise in the ears
- cracked, dry, or scaly skin
- crying
- decrease in frequency of urination
- degenerative disease of the joint
- depersonalization
- diarrhea
- difficulty with moving
- difficulty with passing urine (dribbling)
- dysphoria
- ear pain
- enlarged abdomen or stomach
- euphoria
- excess air or gas in the stomach or intestines
- excessive muscle tone, muscle tension or tightness
- fear
- feeling sad or empty
- hearing loss
- heartburn
- inability to have or keep an erection
- increase in heart rate
- increased hair growth, especially on the face
- increased urge to urinate during the night
- indigestion
- irritation in the mouth
- joint pain or swelling
- leg cramps
- loss of bladder control
- loss of energy or weakness
- loss of interest or pleasure
- loss of strength
- lower abdominal or stomach pain
- muscle aches, pain, stiffness, or weakness
- nervousness
- pain in the back, ribs, arms, or legs
- pain or burning in the throat
- pain or tenderness around the eyes and cheekbones
- paranoia
- pelvic pain
- quick to react or overreact emotionally
- rapid breathing
- rapidly changing moods
- inflammation, redness, or swelling of the gums or mouth
- shaking or trembling
- shivering
- sleepiness
- sunken eyes
- swelling
- swelling of the scrotum
- tender or enlarged gums
- tenderness in the stomach area
- thickening of the skin
- trouble concentrating
- trouble sleeping
- waking to urinate at night
For healthcare professionals
Applies to sirolimus: oral solution, oral tablet.
General adverse events
The most common adverse reactions associated with this drug are peripheral edema, hypertriglyceridemia, hypertension, hypercholesterolemia, creatinine increased, constipation, abdominal pain, diarrhea, headache, fever, urinary tract infection, anemia, nausea, arthralgia, pain, and thrombocytopenia.[Ref]
Metabolic
- Very common (10% or more): Hypertriglyceridemia (up to 58%), hypercholesterolemia (up to 46%), hypokalemia, hypophosphatemia, hyperglycemia
- Common (1% to 10%): Abnormal healing, increased lactic dehydrogenase (LDH), hypokalemia, diabetes mellitus[Ref]
Cardiovascular
- Very common (10% or more): Peripheral edema (up to 58%), hypertension (up to 49%), chest pain (up to 24%), edema (up to 18%), lymphocele
- Common (1% to 10%): Venous thromboembolism (including pulmonary embolism, deep venous thrombosis), tachycardia
- Uncommon (0.1% to 1%): Pericardial effusion (including hemodynamically significant effusions in children and adults), lymphedema
- Rare (less than 0.1%): Pericardial effusion[Ref]
Gastrointestinal
- Very common (10% or more): Constipation (up to 38%), abdominal pain (up to 36%), diarrhea (up to 35%), nausea (up to 31%), vomiting (up to 25%), dyspepsia (up to 25%)
- Common (1% to 10%): Stomatitis[Ref]
Respiratory
- Very common (10% or more): Dyspnea (up to 30%), upper respiratory infection (up to 26%), pharyngitis (up to 21%)
- Common (1% to 10%): Pneumonia, epistaxis, pleural effusion, epistaxis
- Uncommon (0.1% to 1%): Pulmonary hemorrhage
- Rare (less than 0.1%): Alveolar proteinosis
- Frequency not reported: Pleural effusion, alveolar proteinosis[Ref]
Hematologic
- Very common (10% or more): Anemia (up to 33%), thrombocytopenia (up to 30%), blood lactate dehydrogenase increased, blood creatinine increased
- Common (1% to 10%): Thrombocytopenic purpura/hemolytic uremic syndrome, leukopenia, neutropenia, aspartate aminotransferase increased, alanine aminotransferase increased
- Uncommon (0.1% to 1%): Pancytopenia
- Frequency not reported: Capillary leak syndrome[Ref]
Genitourinary
- Very common (10% or more): Urinary tract infection (up to 33%)
- Common (1% to 10%): Pyelonephritis, decline in renal function (creatinine increased) in long-term combination of cyclosporine with this drug, ovarian cysts, menstrual disorders (including amenorrhea and menorrhagia), proteinuria
- Postmarketing reports: Azoospermia[Ref]
Musculoskeletal
- Very common (10% or more): Arthralgia (up to 31%)
- Common (1% to 10%): Bone necrosis[Ref]
Nervous system
- Very common (10% or more): Headache (up to 34%)
- Common (1% to 10%): Osteonecrosis, tremor, insomnia[Ref]
Dermatologic
- Very common (10% or more): Acne (up to 22%), rash (up to 20%)
- Common (1% to 10%): Herpes zoster, herpes simplex
- Uncommon (0.1% to 1%): Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), leukopenia, melanoma, squamous cell carcinoma, basal cell carcinoma[Ref]
Renal
- Very common (10% or more): Creatinine increased (up to 40%)
- Uncommon (0.1% to 1%): Nephrotic syndrome
- Frequency not reported: Focal segmental glomerulo-sclerosis, BK virus associated nephropathy, nephrotic syndrome, higher serum creatinine levels, lower glomerular filtration rates[Ref]
Ocular
- Frequency not reported: Eyelid edema[Ref]
Hepatic
- Common (1% to 10%): Liver function tests abnormal
- Frequency not reported: Hepatic failure, hepatic artery thrombosis[Ref]
Hypersensitivity
- Rare (less than 0.1%): Hypersensitivity reactions, including anaphylactic/ anaphylactoid reactions, angioedema, exfoliative dermatitis, and hypersensitivity vasculitis[Ref]
Other
- Very common (10% or more): Fever (up to 34%), pain (up to 29%)
- Common (1% to 10%): Impaired healing[Ref]
Oncologic
- Common (1% to 10%): Skin cancer, lymphoma/post-transplant lymphoproliferative disorder
- Frequency not reported: Hepatocellular adenoma and carcinoma, testicular adenoma[Ref]
Immunologic
- Common (1% to 10%): Sepsis, pneumonia, pyelonephritis, herpes simplex, fungal, viral, and bacterial infections (such as mycobacterial infections, including tuberculosis, Epstein-Barr virus, CMV, and Herpes zoster), mycobacterial infections (including M tuberculosis), cytomegalovirus (CMV), Epstein-Barr virus
- Frequency not reported: Clostridium difficile enterocolitis[Ref]
See also:
CellCept
Cellcept (mycophenolate mofetil) is used to prevent rejection of a kidney, liver, or heart ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Prograf
Prograf is used to prevent your body from rejecting a heart, liver, or kidney transplant. Learn ...
Rapamune
Rapamune (sirolimus) is used to prevent rejection in people who have received a kidney transplant ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Cyclosporine
Cyclosporine systemic is used for cogan's syndrome, crohn's disease, eczema, evan's syndrome, focal ...
Mycophenolate mofetil
Mycophenolate mofetil systemic is used for autoimmune hepatitis, bullous pemphigoid, cogan's ...
References
1. (2001) "Product Information. Rapamune (sirolimus)." Wyeth-Ayerst Laboratories
2. Vlahakis NE, Rickman OB, Morgenthaler T (2004) "Sirolimus-associated diffuse alveolar hemorrhage." Mayo Clin Proc, 79, p. 541-5
3. Cerner Multum, Inc. "UK Summary of Product Characteristics."
4. Pharmaceutical Society of Australia (2006) APPGuide online. Australian prescription products guide online. http://www.appco.com.au/appguide/default.asp
5. Sola E, Lopez V, Burgos D, et al. (2006) "Pulmonary toxicity associated with sirolimus treatment in kidney transplantation." Transplant Proc, 38, p. 2438-40
6. Wheatcroft S, Byrne J, Thomas M, MacCarthy P (2006) "Life-threatening coronary artery spasm following sirolimus-eluting stent deployment." J Am Coll Cardiol, 47, 1911-2; author reply 1912-3
7. Alkhatib AA (2006) "Sirolimus-induced intractable chronic diarrhea: a case report." Transplant Proc, 38, p. 1298-300
8. Altomare JF, Smith RE, Potdar S, Mitchell SH (2006) "Delayed gastric ulcer healing associated with sirolimus." Transplantation, 82, p. 437-8
9. Aboujaoude W, Milgrom ML, Govani MV (2004) "Lymphedema associated with sirolimus in renal transplant recipients1." Transplantation, 77, p. 1094-6
10. Josef F, Marina K, Alois W (2003) "Sirolimus myopathy." Transplantation, 76, p. 1773-4
11. Mohaupt MG, Vogt B, Frey FJ (2001) "Sirolimus-associated eyelid edema in kidney transplant recipients." Transplantation, 72, p. 162-4
12. Neff GW, Ruiz P, Madariaga JR, et al. (2004) "Sirolimus-associated hepatotoxicity in liver transplantation." Ann Pharmacother, 38, p. 1593-6
More about sirolimus
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Dosage information
- During pregnancy
- Drug class: mTOR inhibitors
- Breastfeeding
- En español
Patient resources
- Sirolimus drug information
- Sirolimus (Oral) (Advanced Reading)
- Sirolimus Tablets
- Sirolimus Oral Solution
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Sirolimus side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.